References
- Eshghabadi M, Shojania A M, Carr I. Isolated granulocytic sarcoma: report of a case and review of the literature. J Clin Oncol 1986; 4: 912–917
- Byrd J C, Edenfield W J, Shields D J, Dawson N A. Extramedullary myeloid cell tumour in acute non-lymphocytic leukemia: a clinical review. J Clin Oncol 1995; 13: 1800–1816
- Neiman R, Barcos M, Bernard C, Bonner H, Mann R, Rydell R E, et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases; a clinical review. Cancer 1981; 48: 1426–1437
- D'Alteroche L, Mor C, Durand V, De Muret A, Benbouker L, Colombat P, et al. Gastric granulocytic sarcoma revealed by a massive digestive hemorrhage. Gastroenterol Clin Biol 1999; 23: 779–782
- Saleh H A, Khatib G. Fatal gastrointestinal bleeding as the primary manifestation of granulocytic sarcoma in a patient with myelodysblastic syndrome. J Fla Med Assoc 1997; 84: 111–114
- Jeon H J, Akagi T. Unsuspected gastric granulocytic sarcoma in a patient with myelodysplastic syndrome. J Korean Med Sci 1996; 11: 68–76
- Nachbaur D, Duba H C, Feichtinger H, Kropshofer G, Nussbaumer W, Schwaighofer H, et al. Polychemotherapy combined with G-CSF-mobilized donor buffy coat transfusion for granulocytic sarcoma after allogeneic BMT for AML. Bone Marrow Transplant 1997; 19: 947–949
- Imrie K, Kovacs M, Selby D, Lipton J, Patterson B J, Pantalony D, et al. Isolated chloroma: the effect of early antileukemic therapy. Ann Intern Med 1995; 123: 351–353
- Chennareddy S B, Chennareddy S P, Polidori G, Eisenberg L, Saleh H A, Bergsman K L. Gastric granulocytic sarcoma as a cause of acute upper gastrointestinal bleeding. Am J Gastroenterol 1996; 91: 609–611
- Breccia M, Mandelli F, Petti M C, D'Andrea M, Pescarmona E, Pileri S A, et al. Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single institution. Leuk Res 2004; 28: 1165–1169
- Huter O, Brezinka C, Nachbaur D, Schwaighofer H, Lang A, Niederwieser D. Succesful treatment of primary extramedullary leukemia (EML) of the uterus with radical surgery, chemotherapy, autologous bone marrow transplantation (BMT) and prophylactic local irradiation. Bone Marrow Transplant 1996; 18: 663–664